Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling
Identification of favorable subgroups of childhood high-hyperdiploid acute lymphoblastic leukemia in a modern therapy era – A retrospective international study of 3,231 patients
Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma
Activity of PROTAC MDM2 Degrader in Primary Leukemia Cells and PDX models
Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry
Unraveling Cellular and Molecular Mechanisms of Relapse in CD19/CD22 Dual-Targeting CAR T Therapy for B-ALL
Response kinetics as a dynamic prognostic marker in patients with multiple myeloma
NUP98 rearrangements in adult AML patients: Evaluation of clinical implications and identification of novel fusion partners
Different Immunotherapeutic Combinations Enhance Specific T Cell Immune Responses Against Leukemic Cells, as well as Leukemic Progenitor and Stem Cells, in Acute Myeloid Leukemia
Identifying Targeted Therapies for CBFA2T3::GLIS2 Acute Myeloid Leukemia